Search is not available for this dataset
name
string | tag
string | uom
string | ddate
int64 | report
int64 | line
int64 | value
string | adsh
string | stmt
string | form
string | fy
int64 | fye
int64 | fp
string | url
string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIO-EN HOLDINGS CORP. | AdditionalPaidInCapital | USD | 20,191,231 | 2 | 16 | 352,681 | 0001104659-20-061458 | BS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | RetainedEarningsAccumulatedDeficit | USD | 20,181,231 | 2 | 17 | -421,991 | 0001104659-20-061458 | BS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | RetainedEarningsAccumulatedDeficit | USD | 20,191,231 | 2 | 17 | -548,147 | 0001104659-20-061458 | BS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | StockholdersEquity | USD | 20,171,231 | 2 | 18 | -209,440 | 0001104659-20-061458 | BS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | StockholdersEquity | USD | 20,181,231 | 2 | 18 | -61,575 | 0001104659-20-061458 | BS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | StockholdersEquity | USD | 20,191,231 | 2 | 18 | -187,731 | 0001104659-20-061458 | BS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | LiabilitiesAndStockholdersEquity | USD | 20,181,231 | 2 | 19 | 11,640 | 0001104659-20-061458 | BS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | LiabilitiesAndStockholdersEquity | USD | 20,191,231 | 2 | 19 | 241,524 | 0001104659-20-061458 | BS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | NetIncomeLoss | USD | 20,181,231 | 6 | 2 | -88,385 | 0001104659-20-061458 | CF | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | NetIncomeLoss | USD | 20,191,231 | 6 | 2 | -126,156 | 0001104659-20-061458 | CF | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | USD | 20,181,231 | 6 | 5 | -102,130 | 0001104659-20-061458 | CF | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | USD | 20,191,231 | 6 | 5 | 11,598 | 0001104659-20-061458 | CF | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | IncreaseDecreaseInAccountsReceivable | USD | 20,181,231 | 6 | 6 | -6,220 | 0001104659-20-061458 | CF | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | IncreaseDecreaseInAccountsReceivable | USD | 20,191,231 | 6 | 6 | -234,884 | 0001104659-20-061458 | CF | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | NetCashProvidedByUsedInOperatingActivities | USD | 20,181,231 | 6 | 7 | -196,735 | 0001104659-20-061458 | CF | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | NetCashProvidedByUsedInOperatingActivities | USD | 20,191,231 | 6 | 7 | -349,442 | 0001104659-20-061458 | CF | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | ProceedsFromIssuanceOfCommonStock | USD | 20,181,231 | 6 | 9 | 236,250 | 0001104659-20-061458 | CF | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | ProceedsFromRepaymentsOfRelatedPartyDebt | USD | 20,181,231 | 6 | 12 | -34,155 | 0001104659-20-061458 | CF | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | ProceedsFromRepaymentsOfRelatedPartyDebt | USD | 20,191,231 | 6 | 12 | 344,442 | 0001104659-20-061458 | CF | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | NetCashProvidedByUsedInFinancingActivities | USD | 20,181,231 | 6 | 13 | -34,155 | 0001104659-20-061458 | CF | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | NetCashProvidedByUsedInFinancingActivities | USD | 20,191,231 | 6 | 13 | 344,442 | 0001104659-20-061458 | CF | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | USD | 20,181,231 | 6 | 14 | 5,360 | 0001104659-20-061458 | CF | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | USD | 20,191,231 | 6 | 14 | -5,000 | 0001104659-20-061458 | CF | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | USD | 20,171,231 | 6 | 16 | 60 | 0001104659-20-061458 | CF | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | USD | 20,181,231 | 6 | 16 | 5,420 | 0001104659-20-061458 | CF | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | USD | 20,191,231 | 6 | 16 | 420 | 0001104659-20-061458 | CF | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | MarketingAndAdvertisingExpense | USD | 20,191,231 | 4 | 4 | 9,607 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | ConsultingExpenses | USD | 20,191,231 | 4 | 5 | 9,440 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | OfficeSuppliesAndTravel | USD | 20,191,231 | 4 | 6 | 1,474 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | FilingFees | USD | 20,181,231 | 4 | 8 | 21,053 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | FilingFees | USD | 20,191,231 | 4 | 8 | 13,428 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | SecretarialExpenses | USD | 20,181,231 | 4 | 9 | 9,614 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | SecretarialExpenses | USD | 20,191,231 | 4 | 9 | 7,035 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | OtherGeneralExpense | USD | 20,181,231 | 4 | 10 | 239 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | OtherGeneralExpense | USD | 20,191,231 | 4 | 10 | 450 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | AccountingFees | USD | 20,181,231 | 4 | 12 | 24,000 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | AccountingFees | USD | 20,191,231 | 4 | 12 | 24,000 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | AuditingFees | USD | 20,181,231 | 4 | 13 | 29,000 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | AuditingFees | USD | 20,191,231 | 4 | 13 | 42,000 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | LegalFees | USD | 20,181,231 | 4 | 14 | 4,479 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | LegalFees | USD | 20,191,231 | 4 | 14 | 18,722 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | OperatingIncomeLoss | USD | 20,181,231 | 4 | 15 | 88,385 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | OperatingIncomeLoss | USD | 20,191,231 | 4 | 15 | 126,156 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | NetIncomeLoss | USD | 20,181,231 | 4 | 17 | -88,385 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | NetIncomeLoss | USD | 20,191,231 | 4 | 17 | -126,156 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | shares | 20,181,231 | 4 | 20 | 77,350,003 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | shares | 20,191,231 | 4 | 20 | 77,350,003 | 0001104659-20-061458 | IS | 10-K | 2,019 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465920061458/0001104659-20-061458-index.html |
BIO-EN HOLDINGS CORP. | CashAndCashEquivalentsAtCarryingValue | USD | 20,191,231 | 2 | 3 | 420 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | CashAndCashEquivalentsAtCarryingValue | USD | 20,201,231 | 2 | 3 | 11,710 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | AccountsReceivableNetCurrent | USD | 20,191,231 | 2 | 4 | 241,104 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | AccountsReceivableNetCurrent | USD | 20,201,231 | 2 | 4 | 15,000 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | AssetsCurrent | USD | 20,191,231 | 2 | 5 | 241,524 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | AssetsCurrent | USD | 20,201,231 | 2 | 5 | 26,710 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | Assets | USD | 20,191,231 | 2 | 6 | 241,524 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | Assets | USD | 20,201,231 | 2 | 6 | 26,710 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | AccountsPayableAndAccruedLiabilitiesCurrent | USD | 20,191,231 | 2 | 9 | 48,968 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | AccountsPayableAndAccruedLiabilitiesCurrent | USD | 20,201,231 | 2 | 9 | 93,238 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | NotesPayableRelatedPartiesClassifiedCurrent | USD | 20,191,231 | 2 | 10 | 380,287 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | NotesPayableRelatedPartiesClassifiedCurrent | USD | 20,201,231 | 2 | 10 | 376,250 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | LiabilitiesCurrent | USD | 20,191,231 | 2 | 11 | 429,255 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | LiabilitiesCurrent | USD | 20,201,231 | 2 | 11 | 469,488 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | Liabilities | USD | 20,191,231 | 2 | 12 | 429,255 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | Liabilities | USD | 20,201,231 | 2 | 12 | 469,488 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | CommonStockValue | USD | 20,191,231 | 2 | 15 | 7,735 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | CommonStockValue | USD | 20,201,231 | 2 | 15 | 7,735 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | AdditionalPaidInCapital | USD | 20,191,231 | 2 | 16 | 352,681 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | AdditionalPaidInCapital | USD | 20,201,231 | 2 | 16 | 352,681 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | RetainedEarningsAccumulatedDeficit | USD | 20,191,231 | 2 | 17 | -548,147 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | RetainedEarningsAccumulatedDeficit | USD | 20,201,231 | 2 | 17 | -803,194 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | StockholdersEquity | USD | 20,181,231 | 2 | 18 | -61,575 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | StockholdersEquity | USD | 20,191,231 | 2 | 18 | -187,731 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | StockholdersEquity | USD | 20,201,231 | 2 | 18 | -442,778 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | LiabilitiesAndStockholdersEquity | USD | 20,191,231 | 2 | 19 | 241,524 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | LiabilitiesAndStockholdersEquity | USD | 20,201,231 | 2 | 19 | 26,710 | 0001104659-21-049930 | BS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | NetIncomeLoss | USD | 20,191,231 | 6 | 2 | -126,156 | 0001104659-21-049930 | CF | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | NetIncomeLoss | USD | 20,201,231 | 6 | 2 | -255,047 | 0001104659-21-049930 | CF | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | USD | 20,191,231 | 6 | 5 | 11,598 | 0001104659-21-049930 | CF | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | USD | 20,201,231 | 6 | 5 | 44,270 | 0001104659-21-049930 | CF | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | IncreaseDecreaseInAccountsReceivable | USD | 20,191,231 | 6 | 6 | -234,884 | 0001104659-21-049930 | CF | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | IncreaseDecreaseInAccountsReceivable | USD | 20,201,231 | 6 | 6 | 226,104 | 0001104659-21-049930 | CF | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | NetCashProvidedByUsedInOperatingActivities | USD | 20,191,231 | 6 | 7 | -349,442 | 0001104659-21-049930 | CF | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | NetCashProvidedByUsedInOperatingActivities | USD | 20,201,231 | 6 | 7 | 15,327 | 0001104659-21-049930 | CF | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | ProceedsFromRepaymentsOfRelatedPartyDebt | USD | 20,191,231 | 6 | 9 | 344,442 | 0001104659-21-049930 | CF | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | ProceedsFromRepaymentsOfRelatedPartyDebt | USD | 20,201,231 | 6 | 9 | -4,037 | 0001104659-21-049930 | CF | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | NetCashProvidedByUsedInFinancingActivities | USD | 20,191,231 | 6 | 10 | 344,442 | 0001104659-21-049930 | CF | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | NetCashProvidedByUsedInFinancingActivities | USD | 20,201,231 | 6 | 10 | -4,037 | 0001104659-21-049930 | CF | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | USD | 20,191,231 | 6 | 11 | -5,000 | 0001104659-21-049930 | CF | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | USD | 20,201,231 | 6 | 11 | 11,290 | 0001104659-21-049930 | CF | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | USD | 20,181,231 | 6 | 12 | 5,420 | 0001104659-21-049930 | CF | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | USD | 20,191,231 | 6 | 12 | 420 | 0001104659-21-049930 | CF | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | USD | 20,201,231 | 6 | 12 | 11,710 | 0001104659-21-049930 | CF | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | MarketingAndAdvertisingExpense | USD | 20,191,231 | 4 | 4 | 9,607 | 0001104659-21-049930 | IS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | ConsultingExpenses | USD | 20,191,231 | 4 | 5 | 9,440 | 0001104659-21-049930 | IS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | ConsultingExpenses | USD | 20,201,231 | 4 | 5 | 1,657 | 0001104659-21-049930 | IS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | OfficeSuppliesAndTravel | USD | 20,191,231 | 4 | 6 | 1,474 | 0001104659-21-049930 | IS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | OfficeSuppliesAndTravel | USD | 20,201,231 | 4 | 6 | 520 | 0001104659-21-049930 | IS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | FilingFees | USD | 20,191,231 | 4 | 7 | 13,428 | 0001104659-21-049930 | IS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | FilingFees | USD | 20,201,231 | 4 | 7 | 14,106 | 0001104659-21-049930 | IS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | SecretarialExpenses | USD | 20,191,231 | 4 | 8 | 7,035 | 0001104659-21-049930 | IS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |
BIO-EN HOLDINGS CORP. | SecretarialExpenses | USD | 20,201,231 | 4 | 8 | 1,106 | 0001104659-21-049930 | IS | 10-K | 2,020 | 1,231 | FY | https://www.sec.gov/Archives/edgar/data/1568139/000110465921049930/0001104659-21-049930-index.html |